DK0696288T3 - Hidtil ukendte quinoxalindionderivater deres fremstilling og anvendelse i lægemidler - Google Patents

Hidtil ukendte quinoxalindionderivater deres fremstilling og anvendelse i lægemidler

Info

Publication number
DK0696288T3
DK0696288T3 DK94914313T DK94914313T DK0696288T3 DK 0696288 T3 DK0696288 T3 DK 0696288T3 DK 94914313 T DK94914313 T DK 94914313T DK 94914313 T DK94914313 T DK 94914313T DK 0696288 T3 DK0696288 T3 DK 0696288T3
Authority
DK
Denmark
Prior art keywords
substd
opt
halo
phenyl
poxy
Prior art date
Application number
DK94914313T
Other languages
English (en)
Inventor
Andreas Huth
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4314591A external-priority patent/DE4314591A1/de
Priority claimed from DE19934344486 external-priority patent/DE4344486A1/de
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0696288T3 publication Critical patent/DK0696288T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94914313T 1993-04-28 1994-04-28 Hidtil ukendte quinoxalindionderivater deres fremstilling og anvendelse i lægemidler DK0696288T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4314591A DE4314591A1 (de) 1993-04-28 1993-04-28 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19934344486 DE4344486A1 (de) 1993-12-21 1993-12-21 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
PCT/DE1994/000493 WO1994025469A1 (de) 1993-04-28 1994-04-28 Neue chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DK0696288T3 true DK0696288T3 (da) 2000-11-13

Family

ID=25925529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94914313T DK0696288T3 (da) 1993-04-28 1994-04-28 Hidtil ukendte quinoxalindionderivater deres fremstilling og anvendelse i lægemidler

Country Status (23)

Country Link
US (2) US5750525A (da)
EP (2) EP0696288B1 (da)
JP (1) JP3530190B2 (da)
KR (1) KR100293880B1 (da)
CN (1) CN1053190C (da)
AT (1) ATE196474T1 (da)
AU (1) AU690550B2 (da)
CA (1) CA2161425A1 (da)
CZ (1) CZ290295B6 (da)
DE (1) DE59409534D1 (da)
DK (1) DK0696288T3 (da)
ES (1) ES2150989T3 (da)
FI (1) FI955140A0 (da)
GR (1) GR3035053T3 (da)
HU (1) HUT73676A (da)
IL (1) IL109397A0 (da)
NO (2) NO308902B1 (da)
NZ (1) NZ265599A (da)
PL (1) PL180332B1 (da)
PT (1) PT696288E (da)
RU (1) RU2140420C1 (da)
SK (1) SK282851B6 (da)
WO (1) WO1994025469A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057304A (en) * 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
DK0647137T3 (da) * 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf
HU217837B (hu) * 1994-05-18 2000-04-28 EGIS Gyógyszergyár Rt. Savamidok, ezeket tartalmazó gyógyászati készítmények és eljárás a hatóanyagok előállítására
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
PT784054E (pt) * 1994-09-27 2002-05-31 Yamanouchi Pharma Co Ltd Derivados de tetraidroquinoxalinadiona 1,2,3,4 e sua utilizacao como antagonistas do receptor glutamato
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19519979A1 (de) * 1995-05-24 1996-11-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
EP0837864A1 (en) * 1995-07-10 1998-04-29 Novartis AG Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
DE19545251A1 (de) * 1995-11-24 1997-05-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
TW448171B (en) * 1996-06-06 2001-08-01 Yamanouchi Pharma Co Ltd Imidazole-substituted quinoxalinedione derivatives
NZ334898A (en) * 1996-10-23 2000-09-29 Warner Lambert Co Substituted gamma aminobutyric acids as pharamceutical agents
CZ141399A3 (cs) * 1996-10-24 1999-07-14 Novartis Ag Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
DE19728326A1 (de) * 1997-06-27 1999-01-07 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19737446A1 (de) * 1997-08-22 1999-02-25 Schering Ag Verfahren zur Herstellung von Phosphonsäurederivaten
BR9811739A (pt) * 1997-09-01 2000-09-19 Kyorin Seiyaku Kk Derivados de ácido quinoxalinacarbóxilico assimetricamente dissubstituìdo em 6,7, seus sais de adição, e processos para a preparação de ambos
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
EP1100504A2 (en) * 1998-07-02 2001-05-23 Eisai Co., Ltd. Pharmaceutical compositions and their uses for treatment of demyelinating disorders
WO2000047567A1 (en) 1999-02-15 2000-08-17 Eisai Co., Ltd. Heterodiazinone derivatives
FR2791982B1 (fr) * 1999-04-06 2002-12-27 Inst Nat Sante Rech Med Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
WO2001096308A1 (en) 2000-06-12 2001-12-20 Eisai Co., Ltd. 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
CN100490835C (zh) * 2004-12-14 2009-05-27 朱木林 一种治疗骨折的药物
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
WO2020124090A1 (en) 2018-12-14 2020-06-18 Eisai R&D Management Co., Ltd. Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds
CN112142797B (zh) * 2020-09-11 2023-07-14 江西师范大学 含磷的喹喔啉类化合物及其制备方法和应用
US11939302B2 (en) * 2020-10-21 2024-03-26 The Governors Of The University Of Alberta Compounds for the treatment of Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
IL90315A0 (en) * 1988-06-01 1989-12-15 Ferrosan As Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
HU221425B (en) * 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DK0647137T3 (da) * 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf

Also Published As

Publication number Publication date
NO20001604D0 (no) 2000-03-28
HUT73676A (en) 1996-09-30
FI955140A7 (fi) 1995-10-27
KR100293880B1 (ko) 2001-09-17
NO20001604L (no) 1995-12-28
CZ290295B6 (cs) 2002-07-17
PL180332B1 (pl) 2001-01-31
NO308902B1 (no) 2000-11-13
PL317075A1 (en) 1997-03-03
PT696288E (pt) 2001-01-31
HU9503078D0 (en) 1995-12-28
EP1002796A3 (de) 2001-09-12
EP0696288A1 (de) 1996-02-14
SK282851B6 (sk) 2002-12-03
ATE196474T1 (de) 2000-10-15
EP1002796A2 (de) 2000-05-24
IL109397A0 (en) 1994-07-31
NZ265599A (en) 1997-10-24
JPH08508037A (ja) 1996-08-27
US5955461A (en) 1999-09-21
CA2161425A1 (en) 1994-11-10
ES2150989T3 (es) 2000-12-16
US5750525A (en) 1998-05-12
CZ282895A3 (en) 1996-02-14
RU2140420C1 (ru) 1999-10-27
AU690550B2 (en) 1998-04-30
SK131895A3 (en) 1996-07-03
NO954315D0 (no) 1995-10-27
FI955140L (fi) 1995-10-27
NO954315L (no) 1995-12-28
FI955140A0 (fi) 1995-10-27
DE59409534D1 (de) 2000-10-26
CN1153517A (zh) 1997-07-02
WO1994025469A1 (de) 1994-11-10
JP3530190B2 (ja) 2004-05-24
AU6675594A (en) 1994-11-21
CN1053190C (zh) 2000-06-07
NO311428B1 (no) 2001-11-26
GR3035053T3 (en) 2001-03-30
EP0696288B1 (de) 2000-09-20

Similar Documents

Publication Publication Date Title
NO954315D0 (no) Nye kinoksalindionderivater, deres fremstilling og anvendelse i legemidler
SE8200815L (sv) Kemisk forening till anvendning som mellanprodukt vid framstellning av vissa triazolforeningar
YU135991A (sh) Novi derivati 3-benzil izoksazola
DE3855239D1 (de) Aminocarbonsäure und Derivate
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
MY108800A (en) 5-aryl isoxazole derivatives, compositions containing them, process for their preparation and their use as herbicides
NZ242243A (en) 2-substituted adenine triphosphate derivatives and pharmaceutical compositions
EP0353955A3 (en) Novel compounds
AU609922B2 (en) Substituted 6-phenyldihydro-3(2h)-pyridazinones, a process for their preparation and pharmaceutical preparations containing these compounds
MX9203262A (es) Agentes quelantes del acido 1,4,7,10-tetraazaciclododecano.
NO913725L (no) Benzen-, pyridin- og pyrimidin-derivater og fremgangsmaatefor deres fremstilling.
NO933425L (no) Nye aktive forbindelser
SE8303987D0 (sv) N-phenylpyrazole derivatives useful as herbicides
ES8301196A1 (es) Procedimiento de preparacion de un nuevo derivado de acido cinamoil-cinamico
DK663588A (da) Purinderivater
PL323032A1 (en) Novel heterocyclic amino-methyl compounds, method of obtaining them and pharmaceutic compositions containing such compounds
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
NO306293B1 (no) Benzoylguanidiner, deres anvendelse for fremstilling av legemiddel eller diagnostikum sÕvel som medikamenter inneholdende dem
DK0577470T3 (da) 2-amino-N(((4-(aminocarbonyl)pyrimidin-2-yl)amino)alkyl) pyrimidin-4-carboxamid-derivater, deres fremstilling og deres anvendelse i terapi
DK0713865T3 (da) Derivater af 2-aminobenzensulfonsyre og 2-aminobenzensulfonylchlorid, fremstilling og anvendelse heraf som syntesemellempro
YU169491A (sh) Derivati triazolopiridazina, postupak za njihovo dobivanje i njihova primena kao herbicida
PT87364A (pt) Process for preparing herbicides compounds comprising anilide
NO20000054D0 (no) Polyhydroksyalkylpyrazinderivater, deres fremstilling og medisiner inneholdende forbindelsene